The Kimberly-Clark/Kenvue transaction is one of the worst-received major merger deals in recent years. Investors wondered why ...

The deal, expected to close in the second half of 2026, comes as Kenvue's Tylenol political fight is heating up.

Kenvue stock soars as Kimberly-Clark agrees to acquire the consumer health giant. Jim Cramer is positive on KVUE shares ...

Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) ...

One of biggest takeovers so far this year will create a global company with annual revenues of roughly $32 billion.

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a huge consumer ...

Kimberly-Clark on Monday said it is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, combining ...

On Monday, major U.S. indexes showed mixed performance — the Dow Jones Industrial Average slipped nearly 0.5% to 47,336.68, ...

In what is being called one of the largest corporate takeovers in years, Kimberly-Clark is buying Tylenol parent company, ...

Kimberly-Clark announces the acquisition of Kenvue, the maker of Tylenol, in a landmark $48.7 billion deal to create a ...

Evercore also said Kimberly’s move expands its footprint into two stable, cash-generative global categories, personal hygiene and consumer health, that have high barriers to entry and rational pricing ...